MediWound Ltd (MDWD)
16.35
-0.30
(-1.80%)
USD |
NASDAQ |
Nov 14, 16:00
16.35
0.00 (0.00%)
After-Hours: 19:54
MediWound Gross Profit Margin (Quarterly): 8.83% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 8.83% |
March 31, 2024 | 12.23% |
December 31, 2023 | 13.47% |
September 30, 2023 | 18.76% |
June 30, 2023 | 23.82% |
March 31, 2023 | 21.74% |
December 31, 2022 | 70.22% |
September 30, 2022 | 41.94% |
June 30, 2022 | 23.84% |
March 31, 2022 | 33.13% |
December 31, 2021 | 28.05% |
September 30, 2021 | 38.53% |
June 30, 2021 | 38.98% |
March 31, 2021 | 41.32% |
December 31, 2020 | 34.89% |
September 30, 2020 | 41.81% |
June 30, 2020 | 30.22% |
March 31, 2020 | 27.72% |
December 31, 2019 | 19.88% |
September 30, 2019 | 22.78% |
June 30, 2019 | 83.22% |
Date | Value |
---|---|
March 31, 2019 | 33.41% |
December 31, 2018 | 30.24% |
September 30, 2018 | 55.01% |
June 30, 2018 | 38.99% |
March 31, 2018 | 26.73% |
December 31, 2017 | 21.51% |
September 30, 2017 | 54.26% |
June 30, 2017 | 29.55% |
March 31, 2017 | 37.04% |
December 31, 2016 | -98.84% |
September 30, 2016 | 8.49% |
June 30, 2016 | -19.38% |
March 31, 2016 | -59.06% |
December 31, 2015 | -158.1% |
September 30, 2015 | -707.8% |
June 30, 2015 | -403.6% |
March 31, 2015 | -161.2% |
December 31, 2014 | -821.0% |
September 30, 2014 | -1.53K% |
June 30, 2014 | -1.75K% |
March 31, 2014 | -240.0% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
8.83%
Minimum
Jun 2024
70.22%
Maximum
Dec 2022
29.97%
Average
28.05%
Median
Dec 2021
Gross Profit Margin (Quarterly) Benchmarks
Kamada Ltd | 44.62% |
Compugen Ltd | 76.84% |
Pluri Inc | -- |
Can Fite Biofarma Ltd | -- |
BiomX Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -71.01% |
Return on Assets | -31.45% |
Return on Invested Capital | -71.01% |
Profit Margin (Quarterly) | -124.5% |
Operating Margin (Quarterly) | -88.56% |
Return on Net Operating Assets | -80.90% |